Lisa Conroy

Lisa Conroy is the Director of Communications at Antidote. She is a seasoned health communications strategist dedicated to understanding the reasons people make the health choices they do, and determining what that means in terms of how scientific data should be communicated. Prior to her role at Antidote, Lisa ran the TEDMED Great Challenges program, a public health initiative funded by RWJF. She also has experience working in pharmaceutical public relations in the areas of respiratory diseases, oncology, and HIV. Lisa holds an MPH from Columbia and a BA in English and International Studies from Northwestern.

Press release: "Antidote Technologies’ Business Development Leader Dave Mauro Named to the 2021 PharmaVOICE 100"

Vator News: "Today's entrepreneur: Laurent Schockmel, CEO of Antidote"

Vator News: "Antidote raises $23M to match patients with clinical trials"

Press release: "Antidote Raises $23 Million to Scale Digital Patient Engagement Services"

Press Release: "Antidote Technologies Registers Over 40,000 COPD Patients for Clinical Trial Matching Services"

Press release: "Antidote Technologies Drives Patient Recruitment for Three Pivotal COVID-19 Clinical Trials"

Press release: "Antidote Technologies Spearheads Recruitment for a COVID Early Treatment Fund Clinical Trial Recently Featured on CBS Program 60 Minutes"

Press release: "Antidote Technologies named a top innovator in new book for pharma industry"

PharmaVOICE 100: "Laurent Schockmel, Creating Transformative Connections"

PharmaVOICE: "Bringing the Patient Voice into Clinical Trials"